We are live on ! Find out more
TVGN icon

Tevogen Inc. Common Stock

56 hedge funds and large institutions have $6.04M invested in Tevogen Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 12 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 12

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

45% more capital invested

Capital invested by funds: $4.16M → $6.04M (+$1.88M)

8% more funds holding

Funds holding: 5256 (+4)

0.01% more ownership

Funds ownership: 0.04%0.05% (+0.01%)

Holders
56
Holders Change
+4
Holders Change %
+7.69%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
24
Reduced
12
Closed
5
Calls
Puts
Net Calls
Net Calls Change

TVGN Hedge Fund Activity: Q2 2025 in Review

56 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q2 2025, worth a combined $6.04M — up 45% from $4.16M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new TVGN positions and 5 closed out — a net gain of 4 holders — while 24 added to existing stakes and 12 trimmed.

The largest buyer was BlackRock, adding an estimated $724K. The largest seller was UBS Group, cutting an estimated $117K.

  • 56 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q2 2025, up from 52 in Q1 2025.
  • Funds reported $6.04M of Tevogen Inc. Common Stock stock for Q2 2025, up 45% quarter-over-quarter.
  • 9 funds opened new Tevogen Inc. Common Stock positions in Q2 2025 and 5 closed out, a net change of +4 holders.
  • The largest Tevogen Inc. Common Stock buyer in Q2 2025 was BlackRock, an estimated $724K added.
  • The largest Tevogen Inc. Common Stock seller in Q2 2025 was UBS Group, an estimated $117K sold.

Based on aggregated 13F filings for Q2 2025.